First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes
Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation
WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry
WATCHMAN FLX™ Device vs Amplatzer™ Amulet™ Occluder: A Meta-Analysis
Amulet IDE: LAA Occluder Performs Well Against Watchman
Left Atrial Appendage Closure for Stroke Risk Reduction in Nonvalvular Atrial Fibrillation - The Cardiology Advisor
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
TCT-93 Left Atrial Appendage Sealing Performance of the Amplatzer Amulet and Watchman FLX Device: A Head-to-Head Comparison
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross Line Extension Compatible with Watchman Delivery System
Current and Future Perspectives on LAAO